More black men to benefit from prostate cancer screening trial

The UK government has announced plans to invite tens of thousands more black men between the ages of 45 and 74 to undergo prostate cancer screening as part of an ongoing research trial aimed at improving detection methods. This development has been praised by charities and campaigners as a landmark advancement in the fight against the disease. The initiative focuses on addressing the disproportionate impact of prostate cancer on black men, who face twice the risk compared to the general male population.

Current screening methods primarily utilize the PSA (prostate-specific antigen) blood test, which has limitations. The National Screening Committee points out that, for most men, the disadvantages of PSA screening outweigh the benefits, except for a smaller group with a harmful genetic mutation and a family history of cancer. While men are encouraged to discuss PSA testing with their doctors, symptoms such as difficulty urinating should never be ignored. The potential harms of widespread screening include unnecessary treatments that can cause side effects like incontinence and erectile dysfunction. Additionally, some prostate cancers grow so slowly that they may not require immediate intervention.

Prostate cancer remains the most commonly diagnosed cancer in men within the UK, affecting about 64,000 men annually and resulting in 12,000 deaths each year. Statistics show that one in eight men will develop the disease during their lifetime, but this risk increases to one in four for black men. To support this targeted screening effort, the government is providing £18 million to the Transform trial, which is examining whether combining PSA tests with other diagnostic tools—such as genetic screening and rapid MRI scans—can improve accuracy and outcomes. All eligible black men who have not recently been tested will have the opportunity to participate.

Health Secretary James Murray emphasized the significance of the trial, stating, “This is a major step forward in how we tackle prostate cancer—focusing on those most at risk, improving the treatments available, and backing the research we need to close the evidence gaps and save lives.” The trial began enrolling participants earlier this year. Prostate Cancer UK expressed enthusiasm about the move, noting that it will enable the charity to provide trusted information to more black men. Experts like Professor Prabhakar Rajan from Queen Mary University of London welcome the increased inclusion of black men in prostate cancer research, highlighting that they have historically been underrepresented despite bearing a higher burden of the disease. The National Screening Committee plans to closely monitor the trial results, with the possibility of expanding screening recommendations in the future based on new evidence

Read the full article from The BBC here: Read More